Takasaki, Shinya, et al. “Clinical Importance of Plasma Drug Concentration of Oral Molecular Targeted Drugs for Renal Cell Carcinoma”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 24, Mar. 2021, pp. 127-36, doi:10.18433/jpps31816.